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Abstract 
Aims: Psychotic symptoms during exposure to high altitude have been linked to accidents or 
near accidents on the mountains. It is thus of great importance to directly identify psychotic 
symptoms in individuals who are exposed to high altitude quickly and reliably on the 
mountain, even in the absence of experienced medical personnel. Psychotic features at high 
altitude frequently include positive psychotic symptoms such as hallucinations, delusions, or 
disorganized thinking/speech. The aim of the current study was to develop the first self-
administered questionnaire (HAPSY Questionnaire) which individuals may use in the future 
to self-assess altitude-related psychotic symptoms on the mountain.  
Methods: We utilized two existing self-rating questionnaires for psychotic symptoms (the 
Psychotomimetic States Inventory, PSI and the Cardiff Anomalous Perception Scale, CAPS) 
as the basis for a two-round Delphi process. As part of this process, additional statements 
were suggested by the 40 Delphi participants.  
Results: Eleven self-administered statements – all of them related to positive psychotic 
symptoms - were identified to be most useful for the self-detection of high altitude-related 
psychotic symptoms on the mountain.  
Conclusion: This is the first self-administered questionnaire which allows identifying high 
altitude-related psychotic symptoms on the mountain. A subsequent validation study is 
needed to address the psychometric properties of this questionnaire. Clinical validation will 
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Introduction 
Professional medical knowledge and high altitude (HA) climbers´ awareness of somatic HA- 
related symptoms such as acute mountain sickness (AMS), HA cerebral edema (HACE) and 
HA pulmonary edema (HAPE) have increased over the past decades, but research on HA-
related psychiatric symptoms is still scarce. We have recently identified isolated high altitude 
psychosis as a medical entity which can occur at HA in the absence of HACE or delirium of 
other causes  (Hufner et al. 2018). However, while organic-induced psychosis (e.g. in the 
context of HACE) are often associated with altered consciousness and prominent somatic 
symptoms such as headache and ataxia (Wu et al. 2006) or fever (Pendlebury et al. 2015), 
individuals with isolated HA psychosis show no or few associated medical symptoms and 
therefore often retrospectively report they descended from the mountain without medical 
assistance (Hufner et al. 2018). Symptoms of isolated HA psychosis were found to occur at a 
mean altitude of approximately 7000 m and to be quickly reversible once lower altitudes are 
reached, which makes it likely that hypoxia plays a major role in the etiology of this disorder 
(Lempert et al. 1994). As with most altitude related symptoms, the incidence of isolated HA 
psychosis is probably decreased at lower altitudes, in our previous work 3800 m was the 
lowest altitude at which it occurred (Hufner et al. 2018). Exhaustion, sleep deprivation 
(Meyhofer et al. 2017), psychological stress and social deprivation might also be contributing 
factors (Daniel and Mason 2015). Other psychiatric disturbances which can occur during 
acute HA exposure are neuropsychological deficits, such as reduced concentration, memory 
and psychomotor performance, alterations in mood (mostly depressed mood) and irritability 
(Bolmont et al. 2000; de Aquino Lemos et al. 2012; Shukitt-Hale et al. 1991; Virues-Ortega et 
al. 2004) . 
 
The nature of psychosis at HA is not yet fully characterized. The Diagnostic and Statistical 
Manual of Mental Disorders, Fifth Edition (DSM-5) (American Psychiatric Association 2013) 
defines psychotic symptoms as hallucinations, delusions, disorganized speech, abnormal 
psychomotor behavior and negative symptoms as well as impaired cognition, depression, 
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and mania (American Psychiatric Association 2013; Barch et al. 2013). Notably, psychotic 
symptoms are transdiagnostic (Fusar-Poli et al. 2017c) and can occur not only in 
schizophrenia but also in mood disorders, substance abuse disorders, due to other medical 
conditions or as part of the syndrome of organic brain dysfunction (classified as delirium in 
DSM-5). The predominant modality of hallucinations my vary depending on the underlying 
condition (e.g. they are often visual in nature in delirium, acoustic in schizophrenia 
(Chaudhury 2010) while “the third man phenomenon” has been found frequently in isolated 
HA psychosis (Hufner et al. 2018)), but  it is inadvisable to give weight to the presence of any 
featural properties of hallucination alone when making a diagnosis (Waters and Fernyhough 
2017). Psychotic symptoms can also be brief and self-remitting and are thus not invariably 
associated with persistent psychotic disorders (Fusar-Poli et al. 2016a; Fusar-Poli et al. 
2017a).  
 
Yet, these psychotic features can have detrimental impact on the persons who experience 
them. This has recently been reported by the media in the case of rescued French climber 
Elisabeth Revol who reportedly removed her boot and suffered severe frostbite on a winter 
ascent to Nanga Parbat. She recollected, while being alone in her tent, feeling the 
hallucinatory presence of a friendly woman who offered her hot tea and requested that she 
took off her boot in return (BBC News 2018). Similarly coauthor I.T. reported that during his 
climb as the medical doctor of an expedition on Dhaulagiri, auditory hallucinations in the form 
of guides suggested he should jump off the East face (an over 2000 m high, very steep  wall) 
to shorten the descent (Hufner et al. 2018). These two prototypical examples highlight how 
psychotic symptoms in such extreme scenarios can expose individuals to high risks. 
Psychotic symptoms at HA are associated with increased accidents or near accidents 
(Hufner et al. 2018). Some climbers retrospectively assign a positive or helpful connotation to 
their psychotic experiences: For example, climber Stephen Venables described psychotic 
symptoms during his expedition to Mt. Everest which in fact helped him to survive when he 
was forced to spend the night above 8000 m unprotected. He reportedly felt the hallucinatory 
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presence of an old man next to him, advising him on how to stay alive, and later he felt the 
hallucinatory presence of various other people warming his extremities (Venables 2013).  
 
It is thus of great importance to detect psychotic symptoms as soon as they emerge in 
individuals at HA, directly on the mountain, even in the absence of experienced medical 
personnel. Given the extreme environment, such an assessment tool for psychotic symptoms 
needs to be simple and easy to administer, as is the case for e.g. AMS scoring (Roach et al. 
2018). It should be designed to rapidly detect emerging psychotic symptoms so that 
appropriate preventive or treatment measures can be implemented accordingly.  
 
The aim of the current study was to develop the first self-rated questionnaire which can be 
used on the mountains, without the need for administration by specialized medical personnel, 
to identify symptoms of psychosis at  HA.  
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Material and Methods 
This study was approved by the local Ethics Committee of Innsbruck Medical University. 
 
The Delphi Method 
The Delphi Method (Brown 1968; Dalkey and Helmer 1963) is an established research tool 
which aims to obtain a reliable, unbiased consensus within a group of experts (see also 
(Brodmann Maeder et al. 2018)). The Delphi participants anonymously join a multiple round 
survey process with controlled opinion feedback. Direct confrontation between the experts is 
avoided to reduce bias, and their feedback/comments are made available to the other 
experts included in the process. An administrative group, entitled “core group” in the present 
study, is responsible for preparing the questionnaires, evaluating and summarizing the 
results, as well as providing anonymous feedback to the Delphi participants until consensus 
is achieved.  
 
Selection of Delphi Experts 
We included the following experts with specific expertise related to the topic of interest: (i) a 
group consisting of HA climbers, who themselves had experienced at least one symptom of 




We included only climbers who themselves had experienced at least one psychotic symptom 
while at HA. The climbers were recruited from a database previously established (Hufner et 
al. 2018) and through personal contact. Contact information of the climbers was obtained 
from the internet, social media or third parties. Climbers whose psychotic episode at HA had 
not been previously validated for the database, were questioned by one of the study authors 
prior to inclusion in the study, in order to ascertain the nature of their symptoms. DSM-5 
dimensional criteria (as reflected in the Clinician-Rated Dimensions of Psychosis Symptom 
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Severity Scale, CRDPSS) were used for assessment of psychosis, at least two criteria had to 
be present, with one of them being delusions, hallucinations or disorganised speech (primary 
symptoms of psychosis)  (American Psychiatric Association 2013; Barch et al. 2013).  
 
Psychosis expert selection 
Psychiatrists with research expertise in psychotic disorders (identified as psychosis research 
experts) were identified using the online scientific citation indexing service “Web of Science”. 
In a first step we identified the highest ranked journals in the field of psychiatry and psychotic 
disorders, namely: World Psychiatry, JAMA Psychiatry, Lancet Psychiatry, Schizophrenia 
Bulletin and Schizophrenia Research. In a 2nd step the authors who were most successful in 
publishing in these high ranked Journals on the topic of psychosis in the past 5 years (2014-
2018) were selected. We included the first 20 hits (i.e. those individuals who had published 
the highest number of articles on “psychosis”) per journal. Contact information was then 
retrieved using internet search engines and social media. Psychiatrists with expertise in the 
clinical management of psychotic disorders (identified as psychosis clinical experts) were 
recruited in the alpine region of Austria, Germany and Italy from large university or regional 
hospitals. Contact information was retrieved using the internet or requested personally. The 
ratings from psychosis research experts and psychosis clinical psychosis experts showed 
similar distributions (Mann-Whitney U test, p>0.05), therefore their answers were analyzed 
as a single group. 
 
In/Exclusion criteria 
Participants of the Delphi process had to be older than 18 years and were required to give 
informed consent. Since the questionnaire was available in English exclusively, only 
participants with fluent knowledge of English were allowed to participate. 
 
Design of Delphi process 
Round one 
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The selected participants were contacted through e-mail/social media and provided with 
information about the study, the informed consent sheet and the Round 1 questionnaire in 
form of a “write in” pdf. The participants (subsequently referred to as the “Delphi experts”) 
were required to individually rate 80 symptom-related statements, which were postulated to 
be potential indicators of psychosis at HA. These statements had been taken from pre-
existing questionnaires (previously developed for a use other than psychosis at HA), namely 
the Psychotomimetic States Inventory (PSI) (Mason et al. 2008) and Cardiff Anomalous 
Perception Scale (CAPS) (Bell et al. 2006). The CAPS is a validated self-report psychometric 
method designed to measure perceptual anomalies. Patients with diagnosed psychotic 
disorders obtain an overall higher CAPS score than the average healthy population (Bell et 
al. 2006). The PSI is a questionnaire designed to measure psychotomimetic states e.g. in the 
context of cannabis and ketamine use or in social deprivation (Mason et al. 2008).  
 
All 80 statements were presented in the order of the original questionnaires, starting with the 
CAPS questions. In an accompanying document Delphi experts were informed about the 
purpose of the Delphi process being the development of a brief self-rating questionnaire to 
detect psychosis at HA, directly on the mountain. Each Delphi expert was asked to indicate 
which of the proposed statements they found either “very helpful” – “helpful” – “moderately 
helpful” – “slightly helpful” – “not helpful at all” to evaluate psychosis at  HA. The climbers 
were asked to rate the statements based on their personal experience while mountaineering. 
The psychosis experts were instructed to answer the statements based on their research or 
clinical expertise. Specific open text sections were provided where Delphi experts were 
encouraged to suggest additional symptoms they deemed important, to explain why they 
performed a certain rating of a statement, and provide suggestions on how to improve the 
outcome of the study. Additionally climbers had the opportunity to describe their own HA 
psychotic experiences.   
Personal information including gender and age was requested from all participants together 
with information pertaining to previous levels of altitude exposure and current altitude of 
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residence. Psychosis experts were also asked to describe the amount of time spent during 
their careers on research and/or clinical work regarding psychosis. All participants were 
offered the opportunity to be acknowledged for their assistance in this study. Delphi experts 
were allowed 4 weeks to complete and return the questionnaires. Two weeks after the 
invitation e-mail, a reminder e-mail was sent out. 
 
Round two 
The set of statements resulting from Round 1, was sent out to the same Delphi experts who 
had participated in Round 1. The statements had to be rated exactly in the same way as 
Round 1. Questions were presented in a random order, so that each statement could be 
evaluated individually, without the influence of a previous similar statement. Once again, the 
Delphi experts had the opportunity to add additional comments. Delphi experts were given 4 
weeks to complete Round 2. Two weeks after the invitation e-mail to Round 2, a reminder e-
mail was sent out.  
 
Evaluation 
Evaluation of open text sections 
The freely inputted text generated from the Delphi experts was collected and presented to 
the study core group. The inputs were divided into statements for inclusion into the 
questionnaire and overall comments for improvement of the study. All members of the core 
group were asked to comment on the statements non-anonymously. The comments were 
then summarized by the two study coordinators (K.H. and F.C.). This summary was 
discussed with the core group members digitally, by telephone/skype conference and/or face 
to face conferences (depending on availability of the core group members) until a consensus 
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The Delphi experts represent two specific groups with different backgrounds regarding HA as 
well as psychosis experience, so statistical evaluation was conducted separately for the two 
groups. As the obtained data for each round showed different characteristics, the 
assessment procedures were adopted ad hoc considering the data distributions. Statistical 
analysis of the results was based on exploring and measuring data distributions by the use of 
descriptive statistics such as Quartiles and Mode. The differences between the distributions 
were tested by the use of non-parametric Mann-Whitney U test.  
 
All Delphi experts´ responses to the proposed statements were transferred to an EXCEL® 
spreadsheet. The response options “very helpful” – “helpful” – “moderately helpful” – “slightly 
helpful” and “not helpful at all” were then coded numerically from 4 to 0 points respectively.  
Data were analyzed using statistical software IBM SPSS Statistics for Windows, Version 24.0 
(IBM Corp 2016) and “R” software (R Core Team 2018).  
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Results 
 
Round 1-Results of Delphi experts´ ratings 
44% (14/32) of all the climbers who were initially identified as having experienced psychosis 
at HA and of which contact information was available, plus 26% (26/102) of all psychosis 
experts of which contact information was available, participated in the study (supplemental 
material Figure 1). Demographic information on Delphi experts as well as data on their HA 
exposures are given in Table 1. 
 
To identify the statements rated most relevant for the detection of psychosis at HA principal 
statistical indices were calculated separately for each statement. Descriptive statistics of the 
data from the climbers´ group differed from the psychosis experts’ group (Mann- Whitney U 
test, p<0.05). Thus, a differential statistical approach considering the structure of the data, 
was applied for the both groups to identify the most relevant statements. In the case of 
psychosis experts’ data, the index Q1 (first quartile: 75% of the values in the data positioned 
above Q1) resulted in the most appropriate threshold value. Selection of statements for 
which Q1 was at least 3 in the Likert scale codification (“helpful” or “very helpful”) ensured 
that at least 75% of experts judged a selected statement as “helpful” or “very helpful”. We 
identified 11 statements from the original questionnaire for inclusion in Round 2 (Table 2).  
In the case of climbers group, generally statements obtained lower ratings than were given 
by the psychosis experts. None of the statements reached a threshold value identified for 
experts´ group, therefore a different approach was used to identify the most relevant 
statements in this group. In order to yield a number of statements comparable with the 
psychosis experts group we selected the statements for which the most frequent values 
(modal values) were at least 2 (“moderately helpful”) (Table 3).  
 
Round 1 - Results of open text fields  
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The open text fields from Round 1 were evaluated by the core group, and seven new 
statements were identified which were found to cover important symptoms not present in the 
Round 1 questionnaire (Table 4). Many comments given in the open text fields by the Delphi 
experts pointed towards interesting topics (e.g. how frequent are the symptoms, do they 
disappear after using dexamethasone, do symptoms occur in a state of dehydration) and 
were deemed to be interesting questions for future research by the core group but not 
suitable for a questionnaire to diagnose psychosis at HA on the mountain. General 
comments by the Delphi experts pertaining to how the study may be improved were taken 
into consideration (e.g. keep the questionnaire short, evaluate the questionnaire also outside 
of a HA setting for comparison, compare the questionnaire with a prodromal screening tool 
and analyse the statements on a continuous scale).  
 
Round 1 - Core group evaluation and analysis 
The core group classified all statements resulting from the Delphi process Round 1 according 
to the PSI Symptom Classification (Delusional Thinking, Perceptual Distortion, Cognitive 
Disorganization, Anhedonia, Mania and Paranoia) (Mason et al. 2008) to make sure that a 
large spectrum of symptoms was also available for ratings in the next round. Since the 
category “anhedonia” was empty, the statement with the most favorable ratings (using the 
mode) was added for evaluation in Round 2.  
 
Round 2 – Results of psychosis experts and climber ratings 
All Delphi experts who participated in the Round 1 were again invited to join Round 2. A 
response rate of 82.5% was attained overall resulting from a 79% contribution from the 
climbers group and 85% from the psychosis experts group. A total of 11 climbers and 22 
psychosis experts took part in Round 2 of this Delphi procedure. The goal of this round was 
to reduce the number of statements to a number considered acceptable to utilize the 
questionnaire on the mountain (10-15 statements was the predefined goal).  
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Similarly to the steps applied in Round 1, descriptive statistics were calculated for both 
groups´ response data and the differences between two groups were found to be statistically 
different (Mann- Whitney test, p-value <0.01). Psychosis experts and climbers data were thus 
again analyzed separately. In this phase, considering the characteristics of the data 
distributions, the choice of consensus statements was based on the mode. Statements with 
the modal value at of least 3 (“helpful” or “very helpful”) were selected in both groups, and 4 
statements reached this threshold in both groups and were included in the next version of the 
questionnaire (Round 2 consensus statements, Table 5).  
 
Finally, the core group aimed to identify those statements, which, over all Delphi participants 
and statistical parameters were those with the highest ratings. As a result, the remaining 18 
statements from Round 2 were analysed as one final set. In order to be included in the final 
questionnaire, a statement had to reach the following conditions together: a Mode of 3 or 4 
(the most frequent values in the statement are “helpful“ or  “very helpful“) and a Median of 3 
or 4 (50% of participants find the statement at least “helpful“) and a Q1 of at least 1 (75% of 
participants find the statement at least “slightly helpful“). Six additional statements were 
identified (Table 6).  
 
Round 2- evaluation of free text  
The consensus statements of Round 1 were presented to the Delphi experts without 
possibility of rating them. It was pointed out, that in case of disagreement, an open text field 
at the end of the questionnaire could be used to express their opinion. No further comments 
were received concerning the consensus statements of Round 1. Additional comments from 
the Delphi experts in Round 2 included the suggestion, to compare the final rating system to 
a prodromal screening tool or to remove the statement on pseudohallucinations. 
 
Finalization of the HAPSY questionnaire by the core group 
In a final core group meeting the following steps were performed.  
15 
Hüfner et al. The HAPSY Questionnaire 2019 
1) Statements relating to the same modality of perceptional distortion were analyzed, leaving 
only the statement with the most comprehensive wording in the questionnaire. We 
acknowledge that this might lead to a loss of accuracy but was done to keep within the frame 
of brevity and to avoid overemphasis of a certain symptom of psychosis at HA through 
simple repetition. This led to the removal of the statements ”You hear voices commenting on 
what you are thinking or doing” and “You hear two or more unexplained voices talking to 
each other” as they were included in the statement  “You hear voices saying words or 
sentences when there is no-one around that might account for it”.  
2) The statement “You are able to distinguish your hallucinations from reality while 
experiencing them” relating to pseudohallucinations was removed because they are not a 
hallmark of psychosis and the core group members believed that only after the episode of 
psychosis were climbers able to distinguish their hallucinations from reality (also argued by 
one of the psychosis experts and one of the climbers). 
3) During our previous work (Hufner et al. 2018), we ascertained that the third man 
phenomenon is a frequently reported perceptual abnormality at HA. However, only the 
sensing of another being (i.e. the statement “You sense the presence of another being, 
despite being unable to see any evidence”), or a conversation with another being (i.e. the 
statement “You have a conversation with a person who is not really there”) were covered by 
the questionnaire, but not so visual hallucinations of another person. Therefore, a decision 
was taken by core group consensus to revise the statement ”You see a person's face in front 
of you, even if no one is in fact there”. This statement was changed to “You see a person or 
a person’s face in front of you even if no one is in fact there”. 
4) A randomization of the single items was performed by permutation of all statements.  
The final HAPSY questionnaire after the Delphi procedure can be seen in Table 7. When 
applied to healthy individuals this questionnaire can be completed in an average time of 1 
minute.  
16 
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Discussion  
In the present study we developed a short, new self-rating questionnaire – the HAPSY 
questionnaire - to measure psychotic symptoms at HA directly on the mountain. To the best 
of our knowledge, this is the first questionnaire to measure symptoms of psychosis at HA. 
We used a Delphi methodology with highly qualified experts to generate this questionnaire. 
 
The ideal group of experts for this Delphi process would have been psychiatrists with 
expertise in HA medicine and specifically psychosis at HA. However, such a group was not 
available when we set out to perform the study mostly due to the fact that psychosis at HA 
has only been recently characterized in more detail in the medical literature. We included two 
groups of experts in this Delphi process: a group consisting of HA climbers, who themselves 
had experienced at least one symptom of psychosis; and a second group consisting of 
psychiatrists specialized in the research and/or clinical management of psychosis. We 
observed differences in data distribution between the two groups during statistical analysis: 
while climbers were instructed to evaluate only symptoms they had already experienced, 
psychosis experts were asked to base their evaluation on their previous experience of all 
patients with psychosis they had evaluated in their career. This lead to fewer “positive” 
ratings in the climbers group. These distributions were taken into account during the 
statistical analysis. 
 
For the development of the HAPSY questionnaire we used statements from pre - existing 
questionnaires (previously developed for a use other than psychosis at HA), namely the 
Psychotomimetic States Inventory (PSI) (Mason et al. 2008) and Cardiff Anomalous 
Perception Scale (CAPS) (Bell et al. 2006). These two questionnaires were chosen on the 
basis of them being self-rating questionnaires for psychotic symptoms, covering domains 
found suitable also in psychosis at HA and free availability under an open license agreement 
(allowing for future distribution of the questionnaire). Additional statements suggested by the 
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Delphi experts were also included. The newly developed questionnaire may be particularly 
useful, in light of the paucity of self-rating questionnaires in psychosis research (Bell et al. 
2006; Mason et al. 2008; Mass et al. 2005). This is due to the phenomenological nature of an 
acute episode of psychosis which is intrinsically gestaltic, i.e. can only be appraised in the 
context of a contextual environment, which makes it especially helpful to have a screening 
questionnaire specifically for the use on the mountain (Fusar-Poli et al. 2017b). In fact, self-
ratings at the time of the first onset of psychosis are difficult to perform, particularly with 
reference to delusions and hallucinations. Problems with concentration and comprehension 
of complex statements can also occur. Additionally, there is a high difficulty of phrasing 
statements to detect hallucinations, delusions and other psychotic symptoms which we partly 
avoided by making use of the two established self-rating questionnaires for psychosis which 
have both been successfully used both in healthy and psychotic individuals (Bell et al. 2006; 
Mason et al. 2008). These two questionnaires also have the advantage of relating to the 
current situation and not making reference to psychotic symptoms experienced in the past 
(Konings et al. 2006). Furthermore, they have been evaluated and validated for use also in 
mentally healthy general populations in which psychotic symptoms can be observed, even in 
the absence of an established mental disorder (Mason and Brady 2009). 
 
The present HAPSY questionnaire consists only of statements concerning perceptual 
abnormalities. This may be due to the fact that positive symptoms of psychosis are more 
prominently remembered and therefore weighted stronger by the experts. This potential bias 
could actually prove advantageous for a self-rating questionnaire since the most easily 
detectable symptoms are measured.  Problems with cognition are much more difficult to 
assess, especially when they are subtle.  
 
Psychotic symptoms at HA can on the one side be a symptom of an organic disease such as 
HACE, infection or dehydration (classified as delirium) or occur in isolation (so called isolated 
HA psychosis) without further psychiatric or somatic pathology (Hufner et al. 2018). The 
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current HAPSY questionnaire can be used to detect symptoms of psychosis but nothing can 
be inferred regarding the origin of these symptoms. Therefore, when psychotic symptoms are 
detected, further measures need to be taken in order to determine which diagnostic category 
they fall into and to allow for appropriate treatment. Altered levels of consciousness 
(operationalized as “reduced level of attention and awareness” in DSM V) can help to 
distinguish delirium from isolated HA psychosis (European Delirium and American Delirium 
2014). However, in the acute setting on the mountain, the priority is to detect such symptoms 
early so that important decisions e.g. regarding route planning and whether or not to continue 
with the climb, will not be undertaken by a person with symptoms of psychosis. Screening of 
psychotic symptoms should thus be performed on a regular, at least daily, basis alongside 
with screening for other HA disorders such as AMS. In addition, such individuals cannot be 
left alone but need to be accompanied during descent. For individuals climbing alone, 
psychotic symptoms could be detected using such a self-rating questionnaire, and cognitive 
techniques such as “reality testing”, which can be practiced beforehand, can then by applied 
once psychotic symptoms have been detected (Smailes et al. 2015). 
 
Our study has several limitations. Since the questionnaire was developed using a Delphi 
process, its inherent deficits are present such as the fact that this is not a controlled study but 
an expert opinion (Dalkey and Helmer 1963). The most important limitation is that the 
questionnaire is not yet validated and will need to be validated against established ratings for 
psychotic symptoms before its use can be recommended. Possible established rating 
instruments which could be used include the Positive and Negative Syndrome Scale  
(PANSS) (Kay et al. 1987), the Brief Psychiatric Rating Scale (BPRS) (Overall and Gorham 
1962) or the Mini-International Neuropsychiatric Interview (M.I.N.I.) (Sheehan et al. 1998). 
Additionally, comparison with and an established psychometric rating for attenuated 
psychotic symptoms (Fusar-Poli et al. 2016b; Fusar-Poli et al. 2017d; Loewy et al. 2011) 
would be ideal. 
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Conclusion and further perspectives 
Using a Delphi process we developed a self-administered questionnaire which allows 
detection of HA-related psychotic symptoms on the mountain. It is planned to use the 
HAPSY questionnaire in a field study at Everest Base Camp (EBC) and validate it using an 
established physician´s rating and a self-rating questionnaire for prodromal symptoms, as 
suggested by one of the Delphi experts e.g. the “Prodromal Questionnaire-16 item (PQ-16)” 
(Loewy et al. 2011). This questionnaire is usually used as a self-report screening measure 
for attenuated psychotic symptoms, therefore it could be ideal to test an emerging psychosis. 
Interestingly, the symptoms listed in the PQ-16 are quite similar to the HAPSY-
Questionnaire. Cut-off values will need to be developed. Further research is needed to 
clinically characterize psychotic symptoms at HA, their pathophysiology and treatment. It will 
be important to compare these features of psychotic symptoms at HA to psychotic symptoms 
occurring at sea level. The HAPSY Questionnaire might prove helpful in accomplishing this. 
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